Medetomidine Hydrochloride api manufacture
27 Inquiries
86347-15-1
Yes
2026-11-25
D-Biotin,Tobramycin base,L(-)-Carnitine base,Polymyxin B sulfate USP,Kanamycin sulfate monohydrate,Finasteride 99% USP
-
Product Details
-
Seller Information
-
Inquiry History
-
Description
1H-Imidazole, 5-[1-(2,3-dimethylphenyl)ethyl]-, hydrochloride (1:1) (CAS No.: 86347-15-1) is supplied by Hangzhou Dawn Ray Pharmaceutical Co.,Ltd, a Manufactory with 5 years on ECHEMI.
Sample is available.
Contact the supplier on this page to request a quotation or the latest price.
ECHEMI Editorial ReferenceMedetomidine Hydrochloride is an agonist of adrenergic alpha-2 receptor, which is used in veterinary medicine for its analgesic and sedative properties.Target: Adrenergic alpha-2 ReceptorMedetomidine, acting at alpha(2A) adrenoceptors, must be present during the encoding process to decrease discrete cue fear memory; however, its ability to suppress contextual memory is likely the result of blocking the consolidation process [1]. Medetomidine had no analgesic effects in alpha(2A)-adrenoce
Medetomidine hydrochloride is a hydrochloride.|An agonist of RECEPTORS, ADRENERGIC ALPHA-2 that is used in veterinary medicine for its analgesic and sedative properties. It is the racemate of DEXMEDETOMIDINE.Basic Info-
Product Name:
1H-Imidazole, 5-[1-(2,3-dimethylphenyl)ethyl]-, hydrochloride (1:1)
Other Name:1H-Imidazole,5-[1-(2,3-dimethylphenyl)ethyl]-,hydrochloride (1:1);1H-Imidazole,4-[1-(2,3-dimethylphenyl)ethyl]-,monohydrochloride;Medetomidine hydrochloride;Domitor;MPV 785;Zalopine;119264-93-6
CAS No.:86347-15-1
Molecular Formula:C13H16N2.ClH
InChIKeys:InChIKey=VPNGEIHDPSLNMU-UHFFFAOYSA-N
Molecular Weight:236.74
Exact Mass:236.108032
EC Number:2017-001-1
DSSTox ID:DTXSID3045691
HScode:2942000000
Categories:
Characteristics-
PSA:
28.7
XLogP3:3.98030
Appearance:White or off white crystalline powder
Melting Point:164-166°C
Boiling Point:381.9°C at 760 mmHg
Flash Point:191.3ºC
Storage Conditions:Refrigerator
Hazard IdentificationClassification of the substance or mixture
Acute toxicity - Category 2, Oral
GHS label elements, including precautionary statements
Pictogram(s)
Signal word Danger
Hazard statement(s) H300 Fatal if swallowed
Precautionary statement(s) Prevention P264 Wash ... thoroughly after handling.
P270 Do not eat, drink or smoke when using this product.
Response P301+P316 IF SWALLOWED: Get emergency medical help immediately.
P321 Specific treatment (see ... on this label).
P330 Rinse mouth.
Storage P405 Store locked up.
Disposal P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
D-Biotin,Tobramycin base,L(-)-Carnitine base,Polymyxin B sulfate USP,Kanamycin sulfate monohydrate,Finasteride 99% USP
-
Location:
1613 Guangyin Building,No.42 E.Fengqi Road,Hangzhou,310012 China.
-
Payment Terms:
TT against copy of documents,L/C
-
Average lead Time:
7 days
-
Total Annual Revenue:
$25 million-$50 million
-
Total Employees:
11-50
-
Year of Establishment:
2011
-
-
Inquiry History27 Inquiries
Country Product Purchase Quantity Date Posted
Canada
86347-15-1
5 KG Dec 30, 2025
United States
Medetomidine Hydrochloride
10 G Feb 25, 2026
United States
1H-Imidazole, 5-[1-(2,3-dimethylphenyl)ethyl]-, hydrochloride (1:1)
1 KG Sep 27, 2026
United States
Medetomidine hcl powder
50 G Jul 4, 2026
United States
Medetomidine hcl powder
50 G Jun 10, 2026
The Dominican Republic
1H-imidazol, 5-[1-(2,3-dimetilfenil)etil]-, clorhidrato (1:1)
5 KG Oct 22, 2026
United States
1H-Imidazole, 5-[1-(2,3-dimethylphenyl)ethyl]-, hydrochloride (1:1)
1 G Oct 19, 2026
The Dominican Republic
1H-Imidazole, 5-[1-(2,3-dimethylphenyl)ethyl]-, hydrochloride (1:1)
10 KG Oct 17, 2026
The Dominican Republic
Medetomidine
5 KG Aug 19, 2026
United States
medetomidine
5 MG May 26, 2026
Canada
Medetomodine HCl
250 G Apr 19, 2026
Canada
Medetomidne hydrochloride
28 G Jan 23, 2026
United States
Medetomidine hydrochloride
100 G Dec 31, 2025
United States
Medetomidine hydrochloride
1 KG May 18, 2025
India
Medetomidine hcl
10 G Apr 29, 2025
United States
1H-Imidazole, 5-[1-(2,3-dimethylphenyl)ethyl]-, hydrochloride (1:1)
5 KG Oct 23, 2026
Paraguay
Medetomidine HCL
1 KG Sep 24, 2026
Canada
Medetomidine HCl
1 KG Aug 26, 2026
Mexico
Medetomidine
50 G Jul 10, 2026
United States
Medetomidine hcl
10 G May 17, 2026 Post an enquiry for this product